The study by Douglas Hanahan and colleagues found that squamous cell tumors of the cervix and skin, driven by Human Papillomavirus type 16 (HPV16), release four immunomodulatory factors ‒ IL-1α, IL-1β, IL-33, and IL-36β ‒ into the bloodstream. Here, IL33 is linked to squamous cell neoplasm.